BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  CytomX Announces Third Quarter 2017 Financial Results and Operational Progress

  As of September 30, 2017, CytomX had cash, cash equivalents and short-term investments of $331.3 million.

  November 7, 2017

   · 

  16 min read
• Business

  Misonix Reports First Quarter Fiscal Year 2018 Financial Results

  Revenue for the first quarter of fiscal year 2018 was $7.3M, an increase of 18% compared with $6.2M in the previous year’s first quarter.

  November 7, 2017

   · 

  10 min read
• Portage Announces its Intention for its Biohaven Shares

  Portage Biotech plans to distribute as stock dividend, a substantial part of the 6,341,500 common shares it holds in Biohaven Pharma.

  November 7, 2017

   · 

  2 min read
• Business

  Inventiva: Third-Quarter 2017 Financial Information

  Revenues of €6.0 million, an increase of 4.6% compared to 2016

  November 7, 2017

   · 

  3 min read